Clinical Trial: This Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clindove Research Studies Focusing on Metabolic and Psychiatric Health. It Involves Non-interventional Screening Activities to Assess Eligibility for Future Clinical Trials.

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07106879) titled 'This Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clindove Research Studies Focusing on Metabolic and Psychiatric Health. It Involves Non-interventional Screening Activities to Assess Eligibility for Future Clinical Trials.' on July 30.

Brief Summary: DOVE-MET-COME-100 is a single site prescreening survey study designed to identify adults who may be eligible for future industry-sponsored clinical trials. A physician will oversee the informed consent process, after which participants will be surveyed on demographics, medical history, current health conditions and symptoms. The study te...